Could gout—a painful form of inflammatory arthritis—play a role in preventing Alzheimer’s disease? In a large study in the United Kingdom, Mass General researchers found that patients who previously had gout had a 24% lower risk of #Alzheimers disease. Gout is caused by high levels of uric acid in the blood, which can cause complications […]
By working with a genetically linked group of 5,000 individuals in Colombia who have a significantly higher predisposition to early-onset #Alzheimer’s disease than any other population in the world, Mass General researcher Yakeel T. Quiroz, PhD (pictured here), is hoping to better understand the subtle changes in the brain that take place prior to an […]
Massachusetts General Hospital’s Dr. Rudolph Tanzi was recognized on TIME Magazine’s list of 100 Most Influential People for his pioneering work in Alzheimer’s research. In writing about him, Maria Shriver noted that Dr. Tanzi is “one of the few scientists who has committed his career to finding a cure for Alzheimer’s, and last year he […]
Dr. Seok-Hyun (Andy) Yun from the Wellman Center of Photomedicine at Massachusetts General Hospital was part of a global team of researchers that was able to observe live taste buds in action for the first time using a specially designed microscope system operated by Dr. Yun and his laboratory team. The study revealed that rather […]
A joint research team from Mass General and Massachusetts Institute of Technology (MIT) may be one step closer to understanding the science of sleep. Using a scanning method that can activate light-sensitive proteins, the researchers found that the activation of cholinergic neurons (those that release the neurotransmitter acetylcholine) in two structures of the brain stem are key to inducing REM […]
Researchers at Massachusetts General Hospital have developed an innovative new way to capture microscopic images of the esophagus using a capsule-sized, light-based imaging tool. This new method, which is currently being tested in clinical trials, could make it possible to screen millions of patients for precursors to esophageal cancer at a fraction of the current cost.